Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
GSK may shift some Relenza manufacturing to mainland
>> article
GSK may shift some Relenza manufacturing to mainland
Editor:bianch Clicks:
0
Date:2009-11-19 15:15:26
Keyword:
GSK Relenza
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
China fines GSK $489m
Police close investigation of GSK bribery
GSK revamps sales reps' compensation
GSK's China sales down 30% on briber...
GSK denies it is considering leaving Chi...
Lower drug prices expected following GSK ...
Police get GSK's help in bribery sca...
Four GSK China execs held for investigat...
GSK to develop traditional Chinese medicine
GSK expands sales force in China
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
